A detailed history of Optas, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Optas, LLC holds 8,363 shares of MRK stock, worth $836,801. This represents 0.22% of its overall portfolio holdings.

Number of Shares
8,363
Previous 8,452 1.05%
Holding current value
$836,801
Previous $1.05 Million 9.27%
% of portfolio
0.22%
Previous 0.27%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$111.15 - $128.97 $9,892 - $11,478
-89 Reduced 1.05%
8,363 $949,000
Q2 2024

Jul 25, 2024

SELL
$123.8 - $132.96 $22,531 - $24,198
-182 Reduced 2.11%
8,452 $1.05 Million
Q1 2024

Apr 17, 2024

BUY
$113.24 - $131.95 $6,907 - $8,048
61 Added 0.71%
8,634 $1.14 Million
Q4 2023

Jan 25, 2024

SELL
$100.18 - $109.02 $89,560 - $97,463
-894 Reduced 9.44%
8,573 $934,000
Q3 2023

Oct 31, 2023

BUY
$102.95 - $114.33 $41,591 - $46,189
404 Added 4.46%
9,467 $974,000
Q2 2023

Jul 20, 2023

BUY
$108.61 - $118.38 $27,043 - $29,476
249 Added 2.83%
9,063 $1.05 Million
Q1 2023

Apr 17, 2023

SELL
$102.94 - $114.86 $19,146 - $21,363
-186 Reduced 2.07%
8,814 $937,000
Q4 2022

Jan 27, 2023

BUY
$87.44 - $112.11 $57,622 - $73,880
659 Added 7.9%
9,000 $998,000
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $394,670 - $443,368
4,669 Added 127.15%
8,341 $718,000
Q2 2022

Aug 01, 2022

BUY
$83.49 - $94.64 $63,619 - $72,115
762 Added 26.19%
3,672 $334,000
Q1 2022

Apr 26, 2022

BUY
$73.51 - $82.4 $213,914 - $239,784
2,910 New
2,910 $240,000
Q1 2021

Apr 19, 2021

SELL
$68.86 - $81.11 $206,029 - $242,681
-2,992 Closed
0 $0
Q4 2020

Jan 27, 2021

SELL
$71.77 - $79.65 $243,228 - $269,933
-3,389 Reduced 53.11%
2,992 $245,000
Q3 2020

Oct 23, 2020

BUY
$73.18 - $82.95 $213,978 - $242,545
2,924 Added 84.58%
6,381 $530,000
Q2 2020

Jul 31, 2020

BUY
$70.42 - $80.13 $243,441 - $277,009
3,457 New
3,457 $268,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Optas, LLC Portfolio

Follow Optas, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.